『Evolution of Virus inactivation methods in manufacture of biologics』のカバーアート

Evolution of Virus inactivation methods in manufacture of biologics

Evolution of Virus inactivation methods in manufacture of biologics

著者： DD ENTERPRISES
無料で聴く

概要

Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses. DNA-based herpesviruses and RNA-based retroviruses are examples of enveloped viruses; DNA-based adenoviruses and RNA-based parvoviruses are examples of nonenveloped viruses.


Visit Site>> Click Here

Copyright 2024 DD ENTERPRISES 社会科学
エピソード
  • Role of CIP SIP Systems in Modern Biopharmaceutical Manufacturing

    Role of CIP SIP Systems in Modern Biopharmaceutical Manufacturing
    2026/02/22

    A well-designed CIP System ensures automated and repeatable cleaning of equipment such as tanks, pipelines, and Pharma Process Vessels. DDE Enterprises provides reliable CIP Cleaning Systems and modular CIP Skids that minimize manual intervention while maximizing cleaning effectiveness.

    www.ddentp.com/smarter-solutions
    続きを読む 一部表示
    2 分
  • Evolution of Virus inactivation methods in manufacture of biologics

    Evolution of Virus inactivation methods in manufacture of biologics
    2024/05/29

    Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


    Visit Site>> Click Here
    続きを読む 一部表示
    19 分
まだレビューはありません